Figure 3.
The glycocalyx components at different outcomes. The difference in glycocalyx levels between the nonsurvivor group and the survivor group is shown from (A–C). *represents p < 0.05 vs. survivor; #represents p < 0.05 vs. Pre. A linear mixed model was used to compare component concentrations between groups. Pre, pre-operation; 0 h, 0 h after the operation; 12 h, 12 h after the operation; 36 h, 36 h after the operation; 3 days, 3 days after the operation; 7 days, 7 days after the operation; HA, hyaluronic acid; SDC-1, syndecan-1; HS, heparan sulfate.